A randomized, controlled trial of prulifloxacin as conversion therapy after intravenous carbapenem in the treatment of acute pyelonephritis caused by third generation cephalosporin resistant pathogens: A pilot study.

So-Ngern, Apichot; Jirajariyavej, Supunnee; Thuncharoon, Huttaya; Khunthupat, Nuttha; Chantarojanasiri, Teerachai; Montakantikul, Preecha

So-Ngern, Apichot; Jirajariyavej, Supunnee; Thuncharoon, Huttaya; Khunthupat, Nuttha; Chantarojanasiri, Teerachai; Montakantikul, Preecha.

Afiliação

So-Ngern A; Faculty of Pharmacy, Siam University, Bangkok, Thailand.
Jirajariyavej S; Department of Medicine, Taksin Hospital, Bangkok, Thailand.
Thuncharoon H; Microbiology Laboratory, Taksin Hospital, Bangkok, Thailand.
Khunthupat N; Department of Pharmacy, Taksin Hospital, Bangkok, Thailand.
Chantarojanasiri T; Bhumirajanagarindra Kidney Institute, Bangkok, Thailand.
Montakantikul P; Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.

Clin Transl Sci ; 16(12): 2709-2718, 2023 12.

Article em En | MEDLINE | ID: mdl-37853952

Assuntos

Carbapenêmicos; Pielonefrite; Adulto; Humanos; Antibacterianos; Carbapenêmicos/uso terapêutico; Ertapenem/uso terapêutico; Fluoroquinolonas/uso terapêutico; Projetos Piloto; Pielonefrite/tratamento farmacológico; Pielonefrite/microbiologia; Cefalosporinas de Terceira Geração

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Adult / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article